#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	880	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1074	43.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	307	309	ACG	48;48;50	A;C;G	48;48;50	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	T879G	SNP	879	879	T	40	40	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	G880A	SNP	880	880	G	41	41	A	9	A	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	A888G	SNP	888	888	A	49	49	G	13	G	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	C897G	SNP	897	897	C	58	58	G	23	G	23	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	T898C	SNP	898	898	T	59	59	C	24	C	24	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	G906T	SNP	906	906	G	67	67	T	34	T	34	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	G908A	SNP	908	908	G	69	69	A	34	A	34	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	A918T	SNP	918	918	A	79	79	T	37	T	37	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	A943G	SNP	943	943	A	104	104	G	67	G	67	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	496	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	172	30.3	0	.	n	.	0	G991T	SNP	991	991	G	152	152	T	47	T	46	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1411	102.4	1	SNP	p	R234F	1	.	.	700	702	TTC	900	902	TTC	143;145;147	T;T;C	143;144;145	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1411	102.4	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1200	1202	CGT	130;133;132	C;G;T	128;133;130	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1411	102.4	0	HET	.	.	.	C261T	.	261	261	C	461	461	C	111	C,T	61,47	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1411	102.4	0	HET	.	.	.	C996A	.	996	996	C	1196	1196	C	118	C,A	70,47	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1411	102.4	0	HET	.	.	.	T999C	.	999	999	T	1199	1199	T	120	T,C	71,48	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2924	Escherichia_coli_EF_Tu	1230	70	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	211	11.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1166	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c30.ctg.1	1791	34.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1554	1556	AAA	13;13;12	A;A;A	13;13;12	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1512	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1688	47.8	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1252	1254	GAA	56;54;55	G;A;A	56;54;55	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	310	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	816	20.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	176	G	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	184	T	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	281	G	279	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	270	C	270	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	240	C	238	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	204	T	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	198	C	196	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	169	C	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	185	A	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	189	A,G	187,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	192	A	191	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	190	T	186	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	191	C	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	186	C	186	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	185	A	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	184	G	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	188	C	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	187	T	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	240	G	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	250	G	250	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	257	T	256	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	210	T	209	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	197	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	153	C	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	141	A	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	94	C	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	84	C	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	8	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	8	G	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	117	G	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	84	T	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	188	C	187	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	533	202.1	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	151	C,T	75,41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	106	95.28	Pasteurella_multocida_16S.l15.c30.ctg.4	109	120.9	0	.	n	.	0	G375A	SNP	375	375	G	75	75	A	98	A	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	106	95.28	Pasteurella_multocida_16S.l15.c30.ctg.4	109	120.9	0	.	n	.	0	G383C	SNP	383	383	G	83	83	C	46	C	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	106	95.28	Pasteurella_multocida_16S.l15.c30.ctg.4	109	120.9	0	.	n	.	0	G385C	SNP	385	385	G	85	85	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	106	95.28	Pasteurella_multocida_16S.l15.c30.ctg.4	109	120.9	0	.	n	.	0	C388G	SNP	388	388	C	88	88	G	19	G	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4048	Pasteurella_multocida_16S	1551	106	95.28	Pasteurella_multocida_16S.l15.c30.ctg.4	109	120.9	0	.	n	.	0	C394T	SNP	394	394	C	94	94	T	4	T	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1208	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1503	42.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	194	196	CGT	30;33;33	C;G;T	30;33;33	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1208	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1503	42.8	0	.	p	.	0	V30I	NONSYN	88	90	GTC	278	280	ATC	36;35;34	A;T;C	36;34;34	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1208	PmrB_1	1092	1092	99.08	PmrB_1.l6.c4.ctg.1	1503	42.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1037	1039	GGC	60;57;54	G;G;C	60;57;53	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1516	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1972	41.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	187	189	AGC	13;13;13	A;G;C	13;13;13	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1516	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1972	41.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	589	591	CTA	40;42;43	C;T;A	40;42;43	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1516	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1972	41.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1108	1110	CAA	49;50;54	C;A;A	49;50;54	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1516	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1972	41.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1207	1209	GGT	64;65;64	G;G;T	64;65;63	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1516	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	1972	41.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1777	1779	GTT	27;27;25	G;T;T	27;27;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	732	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1578	24.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	571	573	GAA	20;19;18	G;A;A	20;19;18	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	732	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1578	24.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	751	753	ACC	11;11;12	A;C;C	11;11;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	732	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1578	24.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	871	873	ACT	20;20;19	A;C;T	20;20;19	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	732	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1578	24.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1261	1263	ATC	15;14;12	A;T;C	15;13;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	858	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1407	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	86	TEM_1+	858	361	98.89	TEM_1+.l15.c30.ctg.1	425	5.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	119	121	CTT	7;7;7	C;T;T	7;7;7	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	86	TEM_1+	858	361	98.89	TEM_1+.l15.c30.ctg.1	425	5.2	0	.	p	.	0	V82I	NONSYN	244	246	GTT	308	310	ATT	4;4;5	A;T;T	4;4;5	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	86	TEM_1+	858	273	99.27	TEM_1+.l15.c30.ctg.2	273	4.0	0	.	p	.	0	H162R	NONSYN	484	486	CAT	48	50	CGT	5;5;5	C;G;T	5;5;5	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	940	aad-	789	789	100.0	aad-.l6.c30.ctg.1	1148	42.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2974	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3515	45.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	479	481	ATC	39;39;38	A;T;C	39;39;38	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2974	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3515	45.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2192	2194	AAG	29;29;30	A;A;G	29;28;30	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1184	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1674	38.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	321	323	GTC	13;13;13	G;T;C	13;13;13	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1184	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1674	38.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1062	1064	TGC	63;64;67	T;G;C	62;63;66	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	338	338	T	25	T	25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	Y49C	NONSYN	145	147	TAT	347	349	TGT	27;27;27	T;G;T	27;26;27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	644	646	GAC	55;55;54	G;A;C	54;55;54	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	920	922	TTA	14;13;13	T;T;A	14;13;13	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1103	1105	AAT	37;37;38	A;A;T	36;36;37	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2596	acrF	3105	2598	98.46	acrF.l6.c30.ctg.1	3004	45.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1890	1890	T	67	T	67	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	674	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1127	32.1	1	SNP	p	R45C	0	.	.	133	135	CGC	384	386	CGC	51;50;51	C;G;C	51;50;51	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	544	acrS	663	663	98.64	acrS.l15.c30.ctg.1	844	33.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	165	167	TTC	32;32;33	T;T;C	32;32;33	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	544	acrS	663	663	98.64	acrS.l15.c30.ctg.1	844	33.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	429	431	GGG	44;42;42	G;G;G	44;42;42	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	712	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1143	33.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	599	601	CTT	70;71;68	C;T;T	69;71;68	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2918	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3153	49.7	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2100	2102	GCA	64;67;67	G;C;A	64;67;67	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2918	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3153	49.7	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2361	2363	ACC	60;61;62	A;C;C	60;61;61	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2918	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3153	49.7	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2670	2672	GCC	36;39;38	G;C;C	36;39;38	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	290	292	GCT	6;6;6	G;C;T	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	410	412	GAG	6;6;6	G;A;G	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	446	448	TGC	5;7;9	T;G;C	5;7;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	I150V	NONSYN	448	450	ATT	629	631	GTT	26;27;28	G;T;T	25;27;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	R200H	NONSYN	598	600	CGC	779	781	CAC	35;33;32	C;A;C	35;33;32	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1064	1066	ATG	45;47;48	A;T;G	44;45;46	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1410	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2427	31.1	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2060	2062	CGC	29;29;28	C;G;C	29;29;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	556	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1227	24.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	859	861	ACC	14;14;14	A;C;C	13;13;13	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	556	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1227	24.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	871	873	TCG	11;11;10	T;C;G	11;10;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	580	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1153	27.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1000	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1605	32.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1317	1319	AAA	13;13;13	A;A;A	12;13;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1000	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1605	32.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1329	1331	GAG	12;13;14	G;A;G	11;13;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1000	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1605	32.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1335	1337	CAC	15;16;15	C;A;C	14;16;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1000	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1605	32.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1389	1391	GAG	16;15;15	G;A;G	16;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1272	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1846	36.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	750	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1152	34.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	864	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1361	34.0	0	.	p	.	0	A146T	NONSYN	436	438	GCT	625	627	ACT	29;28;29	A;C;T	29;28;29	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	556	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	892	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1048	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1614	34.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	855	857	GTC	54;53;53	G;T;C	54;53;53	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1604	emrB	1539	1539	99.74	emrB.l15.c17.ctg.1	1995	43.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	852	854	AAA	51;50;48	A;A;A	51;50;48	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1042	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1618	34.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	844	846	AGC	22;22;21	A;G;C	22;22;21	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	40	emrE_1	333	95	96.84	emrE_1.l15.c4.ctg.1	106	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	872	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1280	34.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	720	722	AGG	21;23;23	A;G;G	21;23;23	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	872	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1280	34.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1110	1112	GAC	17;18;18	G;A;C	17;18;18	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	618	emrR	531	531	100.0	emrR.l15.c4.ctg.1	961	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1218	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1968	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	534	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1040	27.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	373	375	CTG	30;30;32	C;T;G	30;30;32	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	T38I	NONSYN	112	114	ACA	322	324	ATA	21;21;21	A;T;A	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	L42V	NONSYN	124	126	CTA	334	336	GTA	21;21;21	G;T;A	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	487	489	ACG	30;30;30	A;C;G	30;30;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	550	552	GAA	26;26;26	G;A;A	26;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	589	591	GCT	27;28;27	G;C;T	27;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	607	609	GAT	17;17;18	G;A;T	17;17;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	694	696	TCA	9;10;10	T;C;A	9;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	823	825	CAG	11;11;11	C;A;G	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	961	963	GTT	21;19;19	G;T;T	21;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1117	1119	GAT	9;8;8	G;A;T	9;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1285	1287	AAT	9;9;9	A;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1306	1308	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1507	1509	AAA	28;28;27	A;A;A	28;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2242	2244	CAT	35;35;34	C,G;A;T	34,1;35;34	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2296	2298	CAT	24;25;25	C;A;T	24;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2314	2316	AGA	24;24;24	A;G;A	24;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2329	2331	AAT	34;33;32	A;A;T	34;33;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2476	2478	TCC	21;20;19	T;C;C	21;20;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2641	2643	ATT	37;37;36	A;T;T	37;37;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2662	2664	GAT	36;36;37	G;A;T	36;36;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2776	2778	GTT	36;36;36	G;T;T	36;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2430	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4027	32.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3061	3063	CAC	34;34;35	C;A;C	34;34;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	750	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1195	33.6	1	SNP	p	P64S	0	.	.	190	192	CCA	344	346	CCA	62;62;61	C;C;A	61;62;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	750	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1195	33.6	1	SNP	p	P64R	0	.	.	190	192	CCA	344	346	CCA	62;62;61	C;C;A	61;62;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	750	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1195	33.6	1	SNP	p	P64H	0	.	.	190	192	CCA	344	346	CCA	62;62;61	C;C;A	61;62;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	750	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1195	33.6	1	SNP	p	P64L	0	.	.	190	192	CCA	344	346	CCA	62;62;61	C;C;A	61;62;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	750	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1195	33.6	1	SNP	p	P64A	0	.	.	190	192	CCA	344	346	CCA	62;62;61	C;C;A	61;62;60	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	572	gadE	528	528	100.0	gadE.l15.c4.ctg.1	981	31.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	172	gadW	729	168	96.43	gadW.l15.c4.ctg.1	169	24.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	172	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	11.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	12	14	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	172	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	11.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	15	17	TCC	1;1;3	T;C;C	1;1;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	172	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	11.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	18	20	GGG	3;3;3	G;G;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	172	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	11.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	42	44	AAT	10;11;12	A;A;T	10;11;12	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	544	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1053	27.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	311	313	TTA	33;35;34	T;T;A	33;35;34	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	544	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1053	27.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	389	391	ATT	23;23;23	A;T;T	23;23;22	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	544	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1053	27.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	890	892	GGA	26;27;27	G;G;A	26;26;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	544	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1053	27.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	896	898	CCG	27;27;27	C;C;G	27;27;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2227	2229	GAA	42;42;43	G;A;A	42;41;43	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	S83I	0	.	.	247	249	TCG	442	444	TCG	45;45;43	T;C;G	45;45;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	S83L	0	.	.	247	249	TCG	442	444	TCG	45;45;43	T;C;G	45;45;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	S83W	0	.	.	247	249	TCG	442	444	TCG	45;45;43	T;C;G	45;45;43	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	D87V	0	.	.	259	261	GAC	454	456	GAC	39;38;39	G;A;C	39;37;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	D87G	0	.	.	259	261	GAC	454	456	GAC	39;38;39	G;A;C	39;37;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	D87N	0	.	.	259	261	GAC	454	456	GAC	39;38;39	G;A;C	39;37;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	D87Y	0	.	.	259	261	GAC	454	456	GAC	39;38;39	G;A;C	39;37;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2588	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3035	45.8	1	SNP	p	D87H	0	.	.	259	261	GAC	454	456	GAC	39;38;39	G;A;C	39;37;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136I	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136S	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136H	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136G	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136L	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136C	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2238	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2855	42.0	1	SNP	p	R136E	0	.	.	406	408	CGC	625	627	CGC	47;45;47	C;G;C	46;45;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	496	kdpE	678	678	98.23	kdpE.l6.c17.ctg.1	1127	23.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	484	486	CCG	41;43;41	C;C;G	41;43;41	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	496	kdpE	678	678	98.23	kdpE.l6.c17.ctg.1	1127	23.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	637	639	GCC	26;26;26	G;C;C	26;26;25	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	990	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1330	39.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	212	214	TCA	27;26;29	T;C;A	27;26;29	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	364	marA	384	384	99.74	marA.l15.c4.ctg.1	772	25.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	530	532	AGC	23;21;22	A;G;C	23;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	632	634	CAT	11;10;10	C;A;T	11;8;10	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	V45E	0	.	.	133	135	GTG	356	358	GTG	37;36;36	G;T;G	37;36;36	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	I49S	0	.	.	145	147	ATC	368	370	ATC	30;30;32	A;T;C	30;30;32	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	A70T	0	.	.	208	210	GCA	431	433	GCA	26;26;27	G;C;A	26;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R73S	0	.	.	217	219	CGT	440	442	CGT	27;26;27	C;G;T	27;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R73C	0	.	.	217	219	CGT	440	442	CGT	27;26;27	C;G;T	27;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R77C	0	.	.	229	231	CGC	452	454	CGC	24;23;23	C;G;C	24;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R77L	0	.	.	229	231	CGC	452	454	CGC	24;23;23	C;G;C	24;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	L78M	0	.	.	232	234	CTG	455	457	CTG	22;22;22	C;T;G	21;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R94H	0	.	.	280	282	CGC	503	505	CGC	25;25;25	C;G;C	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	R94S	0	.	.	280	282	CGC	503	505	CGC	25;25;25	C;G;C	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	254	marR	435	435	97.7	marR.l15.c4.ctg.1	729	18.4	1	SNP	p	V96E	0	.	.	286	288	GTA	509	511	GTA	25;25;25	G;T;A	25;25;25	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	194	196	TTC	3;3;3	T;T;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	281	283	ATC	13;13;12	A;T;C	13;13;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	299	301	GCC	3;4;4	G;C;C	3;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	302	304	GTG	5;5;5	G;T;G	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	329	331	GAT	14;14;14	G;A;T	14;14;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	350	352	ACC	15;15;15	A;C;C	15;15;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	377	379	TTA	11;11;10	T;T;A	10;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	518	520	CAG	42;44;44	C;A;G	42;44;44	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	557	559	GCC	28;28;28	G;C;C	28;28;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	662	664	GCG	22;23;23	G;C;G	22;23;23	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	866	868	GTT	13;15;16	G;T;T	10;12;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	736	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1582	24.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1028	1028	C	33	C	33	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	59	59	G	34	G	34	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	116	118	CAG	16;19;18	C;A;G	16;19;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	A48V	NONSYN	142	144	GCG	161	163	GTG	19;19;19	G;T;G	18;18;19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	266	268	ATC	25;23;23	A;T;C	24;23;23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	314	316	ATG	15;15;18	A;T;G	15;15;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	407	409	ACC	14;14;13	A;C;C	14;14;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	734	mdtA	1248	1248	97.28	mdtA.l15.c17.ctg.1	1404	26.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	788	790	ACG	21;21;21	A;C;G	21;21;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2000	2002	ACC	48;48;50	A;C;C	48;48;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2393	2395	CAA	37;37;36	C;A;A	36;37;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2561	2563	ATT	23;23;22	A;T;T	23;23;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2645	2647	GTT	42;41;41	G;T;T	42;40;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2753	2755	GAG	30;30;29	G;A;G	30;28;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2981	2983	ATG	23;23;24	A;T;G	23;23;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2882	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3537	43.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3116	3118	GAT	29;30;30	G;A;T	29;30;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	2546	mdtC	3078	2972	98.65	mdtC.l6.c30.ctg.1	3175	41.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	339	341	ATG	19;20;20	A;T;G	19;19;20	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	2546	mdtC	3078	2972	98.65	mdtC.l6.c30.ctg.1	3175	41.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	825	827	ATC	49;51;54	A;T;C	49;51;54	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	2546	mdtC	3078	2972	98.65	mdtC.l6.c30.ctg.1	3175	41.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3141	3143	CAC	3;3;3	C;A;C	3;3;3	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	2546	mdtC	3078	2972	98.65	mdtC.l6.c30.ctg.1	3175	41.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3144	3146	CTC	3;3;3	C;T;C	3;3;2	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	2546	mdtC	3078	90	100.0	mdtC.l6.c30.ctg.3	117	28.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1228	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1787	36.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	169	171	GAA	26;27;27	G;A;A	26;27;27	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1228	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1787	36.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	838	840	GCG	41;41;42	G;C;G	41;41;42	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1228	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1787	36.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1180	1182	ATC	52;48;47	A;T;C	51;48;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1228	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1787	36.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1483	1485	TTT	36;37;37	T;T;T	36;37;37	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1282	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1585	43.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3038	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3531	46.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1099	1101	ACC	44;44;43	A;C;C	44;42;43	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3038	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3531	46.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2341	2343	GAC	52;51;53	G;A;C	51;50;52	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1152	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1483	34.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	638	640	ATC	56;56;55	A;T;C	56;55;55	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1152	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.2	385	18.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	209	211	GGA	13;13;13	G;G;A	13;13;12	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	962	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1554	33.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	581	583	TGT	43;43;43	T;G;T	43;43;43	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	962	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1554	33.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1151	1153	TTG	40;40;40	T;T,G;G	40;39,1;40	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	962	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1554	33.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1361	1363	ACG	16;16;16	A;C;G	16;16;16	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1100	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1583	37.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	760	762	TCC	27;27;28	T;C;C	27;27;27	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	814	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1457	29.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	545	547	ATT	27;31;29	A;T;T	27;31;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	124	126	ATG	18;19;19	A;T;G	18;19;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	190	192	ATC	23;23;25	A;T;C	23;23;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	439	441	CGC	49;48;47	C;G;C	48;48;47	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	805	807	AGC	45;46;45	A;G;C	45;43;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1006	1008	GTG	39;39;40	G;T,A;G	38;37,1;39	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1069	1071	AAC	13;11;10	A;A;C	13;11;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1114	1116	GTC	28;28;28	G;T;C	28;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1144	1146	ATA	47;46;45	A;T;A	47;45;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1252	1254	TCT	36;37;37	T;C;T	36;36;36	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1639	1641	GCG	39;38;38	G;C;G	39;37;38	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1850	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2322	42.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1852	1854	ATC	37;35;35	A;T;C	37;35;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	614	616	GCG	45;45;43	G;C;G	44;45;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	788	790	ACC	26;28;30	A;C;C	26;28;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	860	862	CGC	47;47;49	C;G;C	46;46;49	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	977	979	GCT	32;32;34	G;C;T	31;32;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1061	1063	AAA	18;16;16	A;A;A	18;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1079	1081	CGA	17;17;18	C;G;A	17;17;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1244	1246	GCC	31;29;30	G;C;C	31;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1256	1258	GAT	32;32;33	G;A;T	32;32;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1150	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1872	32.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1673	1675	GCT	11;11;11	G;C;T	11;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3098	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3839	43.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1504	1506	AAG	30;29;28	A;A;G	30;29;28	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3098	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3839	43.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2581	2583	CTG	52;51;52	C;T;G	52;50;51	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	216	mgrB	144	144	100.0	mgrB.l15.c30.ctg.3	164	35.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1946	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2133	49.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	983	985	AAC	40;39;40	A;A;C	40;38;40	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1946	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2133	49.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1529	1531	ATA	63;66;65	A;T;A	63;66;65	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1406	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1694	44.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1327	1329	GAT	64;63;64	G;A;T	64;62;64	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1406	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1694	44.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1330	1332	CTG	62;62;62	C;T;G	62;62;61	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	277	279	TGT	24;25;24	T;G;T	24;25;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	547	549	ACC	40;39;40	A;C;C	40;39;40	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	757	759	GAC	32;32;31	G;A;C	32;32;31	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	1	SNP	p	R15C	0	.	.	43	45	CGC	241	243	CGC	41;39;40	C;G;C	41;39;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	1	SNP	p	S33R	0	.	.	97	99	AGC	295	297	AGC	22;22;21	A;G;C	22;22;21	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	1	SNP	p	G131D	0	.	.	391	393	GGC	589	591	GGC	35;35;35	G;G;C	35;35;32	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	1	SNP	p	R203L	0	.	.	607	609	CGT	805	807	CGT	37;38;37	C;G;T	37;38;37	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	534	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1166	24.6	1	SNP	p	R203C	0	.	.	607	609	CGT	805	807	CGT	37;38;37	C;G;T	37;38;37	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1324	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1316	51.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	971	973	GAG	44;43;44	G;A;G	44;43;44	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1324	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1316	51.6	1	SNP	p	G141D	0	.	.	421	423	GGT	458	460	GGT	65;66;63	G;G;T	65;66;63	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1324	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1316	51.6	1	SNP	p	G141E	0	.	.	421	423	GGT	458	460	GGT	65;66;63	G;G;T	65;66;63	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1324	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1316	51.6	1	SNP	p	R154A	0	.	.	460	462	CGT	497	499	CGT	81;82;79	C;G;T	81;82;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1324	ompF	1089	1089	99.91	ompF.l15.c17.ctg.1	1316	51.6	1	SNP	p	R154D	0	.	.	460	462	CGT	497	499	CGT	81;82;79	C;G;T	81;82;79	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1849	1851	GTG	70;69;69	G;T;G	70;69;69	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1876	1878	TCG	58;57;57	T;C;G	54;54;53	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2491	2493	AAC	41;42;41	A;A;C	41;42;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	1	SNP	p	A85T	0	.	.	253	255	GCG	505	507	GCG	53;52;54	G;C;G	51;48;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	1	SNP	p	D111H	0	.	.	331	333	GAT	583	585	GAT	39;38;38	G;A;T	39;37;38	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2510	parC_2	2259	2259	99.2	parC_2.l6.c17.ctg.1	2726	49.3	1	SNP	p	S129P	0	.	.	385	387	TCC	637	639	TCC	51;51;51	T;C;C	50;51;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1548	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2213	36.5	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1454	1456	AAC	65;65;65	A;A;C	65;64;65	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1548	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2213	36.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1463	1465	GAT	63;63;61	G;A;T	63;63;61	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1502	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1902	42.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	836	838	CAG	54;54;53	C;A;G	54;53;52	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1502	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1902	42.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1310	1312	GAT	43;43;43	G;A;T	42;43;43	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	V146F	0	.	.	436	438	GTT	640	642	GTT	61;61;61	G;T;T	61;61;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1741	1743	CAG	52;54;52	C;A;G	51;52;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1741	1743	CAG	52;54;52	C;A;G	51;52;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1780	1782	CAC	58;58;59	C;A;C	58;58;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1789	1791	CGT	56;56;58	C,A;G;T	55,1;56;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1789	1791	CGT	56;56;58	C,A;G;T	55,1;56;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1795	1797	TCC	55;52;53	T;C;C	55;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1801	1803	CTC	52;51;51	C;T;C	52;51;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1891	1893	ACC	47;47;47	A;C;C	47;47;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1894	1896	CCT	48;47;47	C;C;T	48;47;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4344	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4495	51.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2263	2265	CGT	75;73;73	C;G;T	74;72;72	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	706	322.6	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	299	A	297	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	706	322.6	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	299	A	297	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	706	322.6	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	299	A	297	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	.	n	.	0	A226G	SNP	226	226	A	314	314	G	416	G	415	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	1	SNP	n	A794T	0	.	.	794	794	A	882	882	A	344	A	340	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	1	SNP	n	A794G	0	.	.	794	794	A	882	882	A	344	A	340	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	1	SNP	n	G926C	0	.	.	926	926	G	1014	1014	G	331	G	328	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	1	SNP	n	G926A	0	.	.	926	926	G	1014	1014	G	331	G	328	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	1	SNP	n	G926T	0	.	.	926	926	G	1014	1014	G	331	G	328	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	A79G,T	.	79	79	A	167	167	A	326	A,G,T	231,90,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	C719T	.	719	719	C	807	807	C	297	C,T	171,125	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	T273A	.	273	273	T	361	361	T	352	T,A	267,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	C183T	.	183	183	C	271	271	C	300	C,T	194,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	A250T	.	250	250	A	338	338	A	383	A,T	294,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	T90C	.	90	90	T	178	178	T	327	T,C	243,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	G474A	.	474	474	G	562	562	G	394	G,A	301,90	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	A253T	.	253	253	A	341	341	A	377	A,T	288,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.2	1088	324.6	0	HET	.	.	.	C194T	.	194	194	C	282	282	C	331	C,T	250,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	139	100.0	rrsB+.l15.c30.ctg.3	139	87.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	120	A,G	119,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	122	C,G	121,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	130	C	129	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	122	G	121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	120	G	119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11802	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.5	141	65.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	97	T,C	95,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	656	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	893	39.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	538	soxR	465	465	100.0	soxR.l15.c30.ctg.1	879	32.9	1	SNP	p	R20H	0	.	.	58	60	CGC	271	273	CGC	54;56;58	C;G;C	54;55;58	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	538	soxR	465	465	100.0	soxR.l15.c30.ctg.1	879	32.9	1	SNP	p	G121D	0	.	.	361	363	GGT	574	576	GGT	41;42;43	G;G;T	41;42;43	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	354	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	722	26.0	1	SNP	p	A12S	0	.	.	34	36	GCA	232	234	GCA	36;35;35	G;C;A	36;35;35	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1552	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1956	42.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
